Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

Market Cap	2.33B +19.7%
Revenue (ttm)	735.18M -15.8%
Net Income	8.42M -79.4%
EPS	0.04 -80.5%
Shares Out	235.30M
PE Ratio	277.41
Forward PE	n/a
Dividend	0.03 (0.29%)
Ex-Dividend Date	n/a

Volume	8,162,978
Average Volume	12,548,191
Open	9.90
Previous Close	10.17
Day's Range	9.90 - 10.17
52-Week Range	8.66 - 15.19
Beta	0.12
RSI	48.80
Earnings Date	Apr 30, 2026

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,388
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002873

Financial Performance

In 2025, SHE:002873's revenue was 749.72 million, a decrease of -12.57% compared to the previous year's 857.55 million. Earnings were 9.11 million, a decrease of -82.59%.